Vascular Access Devices Market Size & Growth Forecast 2027–2036, By Segments (End Use, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Vascular Access Devices Market size was valued at USD 9.6 billion in 2026 and is projected to grow at a 4.47% CAGR from 2027 to 2036, reaching USD 14.87 billion by 2036. The industry revenue for 2027 is estimated at USD 9.96 billion.

• Base Year Value (2026): USD 9.6 billion
• CAGR (2027-2036): 4.47%
• Forecast Year Value (2036): USD 14.87 billion
• Historical Data Period: 2022-2026
• Largest Region: North America
• Forecast Period: 2027-2036

Vascular Access Devices Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America leads with 56.02% share due to strong hospital infrastructure, high procedure volumes, and widespread use across oncology, dialysis, and acute care infusion therapies.
  • Asia Pacific grows at 5.47% CAGR driven by rising healthcare access, expanding hospital capacity, and increasing adoption of infusion therapy and structured vascular access practices.

• Segment Momentum:

  • Short PIVCs accounted for 46.64% of the market in 2026 due to their widespread use for routine fluid administration, medication delivery, and bedside vascular access across hospital and outpatient settings.
  • Midline Catheters are the fastest-growing product segment because they address intermediate-duration therapy needs, offering a practical alternative between short peripheral access and more invasive central venous placement.

• Market Expansion Drivers:

  • Rising prevalence of chronic cardiovascular and cancer conditions increasing vascular access procedure volumes.
  • Growing geriatric population driving long-term intravenous therapy and dialysis device demand.
  • Technological advancements in catheter and graft design improving clinical efficiency and patient outcomes.

• Leading Market Participants:

  Key players in the vascular access devices market include Becton, Dickinson and Company (United States), B. Braun Melsungen AG (Germany), Teleflex Incorporated (United States), Terumo Corporation (Japan), Medtronic plc (Ireland), ICU Medical, Inc. (United States), AngioDynamics, Inc. (United States), Cook Medical LLC (United States), Vygon SA (France), Smiths Medical (United Kingdom).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2026 Market Size: USD 9.6 billion
  • 2027 Estimated Market Size: USD 9.96 billion.
  • Projected Market Size: USD 14.87 billion by 2036
  • Growth Forecasts: 4.47% CAGR (2027-2036)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Hospitals (End Use) | Short Peripheral Intravenous Catheter (Short PIVCs) (Product)
  • Emerging Opportunity Segment: Ambulatory Care Centers (End Use) | Midline Catheters (Product)

Market Growth Drivers and Industry Trends

Rising prevalence of chronic cardiovascular and cancer conditions increasing vascular access procedure volumes

The growing burden of chronic cardiovascular and cancer conditions will drive the vascular access devices market growth by increasing the number of patients requiring repeated intravenous access for diagnosis and treatment. Patients undergoing chemotherapy, medication administration, fluid therapy, blood sampling, and other prolonged clinical interventions often require reliable vascular access solutions suited to the duration and intensity of treatment. As chronic diseases require ongoing medical management, healthcare providers increasingly depend on catheters, ports, and other access devices that can support repeated procedures while reducing complications associated with frequent needle insertion. The expanding use of hospital-based and outpatient therapies further increases the need for dependable vascular access during complex treatment pathways.

Growing geriatric population driving long-term intravenous therapy and dialysis device demand

An expanding geriatric population is increasing the need for long-term medical interventions, supporting vascular access devices market demand for patients requiring intravenous therapies and dialysis. Older adults are more likely to experience multiple chronic conditions that necessitate extended medication delivery, nutritional support, fluid administration, or renal replacement therapy. Long-term vascular access devices provide clinicians with a practical means of maintaining access for repeated treatment while limiting the need for repeated peripheral venipuncture. In dialysis care, durable access solutions are particularly important for patients receiving recurring treatments, making reliable catheter and graft technologies an integral part of ongoing clinical management.

Technological advancements in catheter and graft design improving clinical efficiency and patient outcomes

Technological improvements in catheter and graft design are enhancing the performance and usability of vascular access solutions, thereby supporting market development. The vascular access devices market is benefiting from innovations focused on improving catheter flexibility, insertion accuracy, blood-flow characteristics, infection resistance, and device durability. Improvements in graft materials and construction can likewise support more reliable vascular connections and facilitate access in patients with challenging clinical requirements. Enhanced device designs can help healthcare professionals manage procedures more efficiently while reducing risks associated with complications such as infection, thrombosis, catheter malfunction, and inadequate vascular access.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising prevalence of chronic cardiovascular and cancer conditions increasing vascular access procedure volumes	2.10%	High	North America, Europe	High	Near Term
Growing geriatric population driving long-term intravenous therapy and dialysis device demand	1.90%	High	Asia Pacific, North America	High	Mid Term
Technological advancements in catheter and graft design improving clinical efficiency and patient outcomes	1.60%	High	Europe, North America	Medium	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

Holding the largest share of the vascular access devices market at 56.02% in 2026, North America benefits from advanced healthcare infrastructure, high utilization of hospital-based procedures, and established practices for intravenous and long-term vascular access. The region's substantial demand is supported by the management of chronic illnesses requiring recurring therapies, along with widespread use of vascular access solutions in oncology, critical care, surgery, and infusion treatment. Strong emphasis on patient safety, infection prevention, and procedural efficiency also encourages adoption of technologically advanced devices. Established clinical expertise and continued healthcare investment further reinforce the region's position as a mature and highly developed market.

Asia Pacific is projected to be the fastest-growing regional market as healthcare systems expand and access to specialized medical treatment improves. Rising hospital capacity, increasing treatment of chronic diseases, and growing demand for infusion-based therapies are broadening the use of vascular access devices across the region. Healthcare modernization is also encouraging greater adoption of standardized procedures and devices designed to improve patient safety and reduce complications. Expanding medical infrastructure, improving clinical capabilities, and increasing awareness of infection-control practices are creating favorable conditions for wider utilization across hospitals and specialized treatment centers.

Key Country Insights

United States

Advanced Clinical Adoption

The U.S. continues to prioritize vascular access devices that improve patient safety, reduce catheter-related complications, and support outpatient care. Healthcare providers are adopting technologies with enhanced infection prevention features and workflow efficiency across acute and ambulatory settings.

Japan

Precision Care Integration

Japan focuses on vascular access devices that support precise catheter placement and long-term patient management in aging care settings. Healthcare institutions increasingly value products that enhance procedural consistency while minimizing patient discomfort during repeated treatments.

South Korea

Hospital Technology Uptake

South Korea is expanding the use of vascular access devices that complement digitally enabled hospital workflows and advanced clinical practices. Hospitals increasingly evaluate products that simplify insertion procedures and strengthen infection prevention initiatives.

Germany

Quality-Focused Procurement

Germany emphasizes clinically validated vascular access devices that align with stringent hospital procurement standards and infection control protocols. Demand is supported by healthcare providers seeking durable products that integrate efficiently into standardized vascular access procedures.

France

Infection Control Focus

France places strong emphasis on vascular access devices designed to improve patient safety through effective infection prevention and standardized clinical protocols. Hospitals continue to favor products that support reliable performance across intensive and long-term care environments.

Italy

Critical Care Optimization

Italy is reinforcing the adoption of vascular access devices that improve treatment continuity in intensive care and surgical settings. Healthcare providers are prioritizing dependable device performance alongside easier handling for clinicians managing complex patient cases.

Segment Leadership and Growth Trends

 

End Use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Care Centers (Fastest-Growing Segment)

Hospitals held the dominant position in the vascular access devices market, accounting for a 52.71% share in 2026. Their leadership is closely linked to the high volume and diversity of procedures requiring reliable vascular access, including medication administration, fluid delivery, blood sampling, and long-term patient management. Hospitals manage a broad range of acute and complex cases, creating sustained demand for vascular access solutions across multiple clinical departments. Continued emphasis on safe infusion practices, efficient patient care, and appropriate vascular access selection further supports the segment's established market position.

Ambulatory care centers are the fastest-growing segment, reflecting the broader shift toward outpatient and lower-acuity healthcare delivery. Increasing adoption of minimally invasive procedures and same-day treatment models is creating greater demand for vascular access devices that support efficient clinical workflows and patient throughput. Ambulatory settings also benefit from growing preferences for convenient care outside traditional inpatient environments. As healthcare providers continue expanding outpatient services and prioritizing cost-efficient treatment pathways, demand for vascular access solutions across ambulatory facilities is gaining momentum.

Product Segment Analysis: Short Peripheral Intravenous Catheter (Short PIVCs) (Largest Segment) vs Midline Catheters (Fastest-Growing Segment)

The short peripheral intravenous catheter (short PIVCs) segment accounted for the largest share of the vascular access devices market at 46.64% in 2026. Its strong market position stems from its broad applicability across routine clinical procedures, particularly for short-term intravenous therapy, medication delivery, and fluid administration. The widespread use of peripheral access in hospitals and other care environments, combined with the relative simplicity of catheter placement, supports consistent demand. Continued attention to patient safety, catheter performance, and efficient infusion practices further reinforces the importance of short PIVCs across everyday clinical care.

Midline catheters are advancing at the fastest pace as healthcare providers increasingly seek vascular access options that bridge the requirements between short-duration peripheral access and longer-term vascular access solutions. Their suitability for therapies requiring extended access can support improved treatment continuity while reducing the need for repeated peripheral catheter placement. Growing adoption of outpatient care, home-based treatment pathways, and longer-duration intravenous therapies is creating additional opportunities for midline use. Greater clinical awareness of appropriate vascular access selection and efforts to improve patient comfort and treatment efficiency are further supporting segment expansion.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
End Use	Hospitals, Ambulatory Care Centers, Other	Hospitals	Ambulatory Care Centers
Product	Short Peripheral Intravenous Catheter (Short PIVCs), Huber Needles, Midline Catheters, Peripherally Inserted Central Catheter (PICCs), Central Venous Catheter (CVCs), Dialysis Catheters, Implantable Ports	Short Peripheral Intravenous Catheter (Short PIVCs)	Midline Catheters

Competitive Landscape and Market Positioning

Top players in the vascular access devices market:

1. Becton Dickinson and Company (United States)

2. B. Braun Melsungen AG (Germany)

3. Teleflex Incorporated (United States)

4. Terumo Corporation (Japan)

5. Medtronic plc (Ireland)

6. ICU Medical Inc. (United States)

7. AngioDynamics Inc. (United States)

8. Cook Medical LLC (United States)

9. Vygon SA (France)

10. Smiths Medical (United Kingdom)

The vascular access devices market is evolving with increasing focus on patient safety, infection prevention, and long-term treatment efficiency. Manufacturers are introducing advanced catheter systems and integrated monitoring technologies designed to improve procedural accuracy and clinical outcomes. Regulatory emphasis on quality standards and hospital-acquired infection reduction is also encouraging continuous innovation within the market.

Industry Development/News

Company Name	Date	Key Development
Teleflex	Jul-24	Teleflex announced a strategic corporate restructuring to separate into two distinct entities while simultaneously acquiring Biotronik’s cardiovascular business for €760 million. This acquisition significantly broadens the company’s interventional portfolio, incorporating advanced catheter-based technologies and strengthening its competitive standing within the vascular access and broader cardiovascular device market segments.
Harsoria Healthcare	Jul-24	Harsoria Healthcare secured $20 million in funding led by Tata Capital Healthcare Fund II to support a significant scale-up of its manufacturing capacity and research and development operations. The capital injection is directed toward accelerating the commercial growth and market reach of its comprehensive portfolio of single-use medical devices, including key vascular access products.
RoddyMedical, Inc.	Jul-24	RoddyMedical secured investment from Nurse Capital to facilitate the commercialization and operational scaling of its SecureMove-TLC wearable device. The technology is engineered to mitigate risks associated with medical tubing management, directly addressing clinical workflow efficiency and patient safety requirements in healthcare environments utilizing vascular access devices.
Zonova	Jul-24	Zonova raised £2.1 million in seed funding led by THENA Capital to advance proprietary antimicrobial material technologies. The investment focuses on developing next-generation surface coatings designed to enhance infection resistance in medical devices, specifically targeting clinical applications within the vascular access market to improve patient safety outcomes and infection control protocols.
BD	Nov-23	BD launched the PIVO Pro needle-free blood collection device, designed for integration with both short-term peripheral and long-term peripheral intravenous catheters. This innovation complements the company's existing portfolio, including the Nexiva system and the NearPort IV Access, reflecting a strategic effort to enhance device functionality and streamline blood collection procedures in vascular access care.
B. Braun Medical Inc.	Oct-23	B. Braun Medical Inc. introduced the Introcan Safety 2 IV Catheter, incorporating Multi-Access Blood Control technology. This product release represents a technical advancement in passive needlestick prevention, specifically engineered to reduce clinician exposure to bloodborne pathogens during IV procedures, thereby addressing critical safety and clinical requirements in the vascular access device market.